Exhibit 107
Calculation of Filing Fee Tables
Form S-8
(Form Type)
MAIA Biotechnology, Inc.
(Exact Name of Registrant as Specified in its Charter)
Table 1: Newly Registered Securities
Security Type |
Security Class Title | Fee Calculation Rule |
Amount Registered(1) |
Proposed Maximum Offering Price Per Unit |
Maximum Aggregate Offering Price |
Fee Rate | Amount of Registration Fee |
|||||||||||||||||
Equity | Common Stock, $0.0001 par value per share | Other(3) | 1,956,993 | (2) | $ | 2.17 | (3) | $ | 4,246,675 | $ | 0.0001102 | $ | 467.99 | |||||||||||
Total Offering Amount |
|
$ | 4,246,675 | $ | 467.99 | |||||||||||||||||||
Total Fees Previously Paid |
|
| ||||||||||||||||||||||
Total Fee Offsets |
|
| ||||||||||||||||||||||
Net Fee Due |
|
$ | 467.99 |
(1) | Pursuant to Rule 416(a) under the Securities Act of 1933, as amended (the Securities Act), this Registration Statement shall also cover an indeterminate number of additional shares of common stock, $0.0001 par value per share (the Common Stock) of MAIA Biotechnology, Inc. (the Registrant), which become issuable under the 2021 Plan (as defined below) by reason of any stock splits, stock dividends, reorganizations, mergers, consolidations, recapitalizations or other similar transactions. |
(2) | Represents shares of Common Stock that were automatically added to the shares authorized for issuance under the 2021 Equity Incentive Plan, as amended (the 2021 Plan) on May 25, 2023 pursuant to an evergreen provision contained in the 2021 Plan. On May 25, 2023, the stockholders of the Registrant approved an amendment to the 2021 Plan to include an automatic increase in the aggregate number of shares reserved for awards under the 2021 Plan, commencing on the date of stockholder approval of the amendment, and then each January 1 following thereafter, and ending on (and including) January 1, 2032 (each an Increase Date), in an amount equal to ten (10%) of the total number of shares of Common Stock on a fully diluted basis outstanding on December 31 of the preceding calendar year; provided that, the board of directors of the Registrant may act prior to any Increase Date to provide that there will be no increase for such year or that the increase for such year will be a lesser number of shares than provided in the 2021 Plan. |
(3) | Estimated solely for the purpose of calculating the registration fee pursuant to Rules 457(c) and 457(h) under the Securities Act, based on the average of the high and low sales prices of the Common Stock as reported on NYSE American on June 27, 2023, which was $2.17 per share. |